Ladenburg Thalmann Financial Services’s Opus Genetics IRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$0 Sell
12
-7
-37% -$53 ﹤0.01% 5535
2019
Q3
$0 Sell
19
-47
-71% -$654 ﹤0.01% 5480
2019
Q2
$1K Sell
66
-8
-11% -$181 ﹤0.01% 5168
2019
Q1
$2K Buy
74
+55
+289% +$1.82K ﹤0.01% 4979
2018
Q4
$1K Hold
19
﹤0.01% 5103
2018
Q3
$1K Sell
19
-8
-30% -$618 ﹤0.01% 5053
2018
Q2
$1K Hold
27
﹤0.01% 5030
2018
Q1
$1K Buy
27
+8
+42% +$727 ﹤0.01% 5030
2017
Q4
$2K Hold
19
﹤0.01% 4810
2017
Q3
$2K Buy
19
+11
+138% +$1.19K ﹤0.01% 4702
2017
Q2
$1K Buy
8
+6
+300% +$1.17K ﹤0.01% 4785
2017
Q1
$1K Sell
2
-4
-67% -$519 ﹤0.01% 4757
2016
Q4
$0 Hold
6
﹤0.01% 4966
2016
Q3
$0 Hold
6
﹤0.01% 4884
2016
Q2
$1K Sell
6
-16
-73% -$2.24K ﹤0.01% 4626
2016
Q1
$3K Buy
22
+4
+22% +$666 ﹤0.01% 4284
2015
Q4
$3K Sell
18
-21
-54% -$4.47K ﹤0.01% 4258
2015
Q3
$10K Hold
39
﹤0.01% 3551
2015
Q2
$12K Hold
39
﹤0.01% 3576
2015
Q1
$14K Buy
39
+3
+8% +$1.09K ﹤0.01% 3424
2014
Q4
$12K Hold
36
﹤0.01% 3325
2014
Q3
$14K Hold
36
﹤0.01% 2913
2014
Q2
$15K Buy
+36
New +$16.4K ﹤0.01% 2863

Other funds holding IRD

Ladenburg Thalmann Financial Services's IRD Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Opus Genetics (IRD) stake by 37% in Q4 2019, selling an estimated $53 and leaving 12 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5535.

Ladenburg Thalmann Financial Services first reported a position in IRD in Q2 2014 and has held it in 23 quarters since. The position peaked at $15K in Q2 2014. 17 funds tracked by Wall St. Rank hold IRD as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 12 shares of Opus Genetics worth $0 as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 7 Opus Genetics shares in Q4 2019, an estimated $53.
  • Opus Genetics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5535 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Opus Genetics in Q2 2014 and has held it in 23 quarters since.
  • Ladenburg Thalmann Financial Services's Opus Genetics position peaked at $15K in Q2 2014.
  • 17 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.